Table 3.
Genotypes, previous treatment courses and treatment response of 11 patients with haemoglobinopathies and chronic hepatitis C who received direct acting antivirals.
| Patient | Genotype | Previous treatment | Response |
|---|---|---|---|
| 1 | 1b | PegIFN 12 months | NR |
| 2 | 1b | IFN 12 months | NR |
| 3 | 1b | IFN 18 months/ PegIFN 6 months | Relapse/ NR |
| 4 | 1b | PegIFN 8 months/ PegIFN + RBV 6 months | NR/ NR |
| 5 | 3 | PegIFN 6 months | NR |
| 6 | 3 | IFN 12 months | NR |
| 7 | 3 | IFN 12 months | NR |
| 8 | 1a | PegIFN 8 months/ PegIFN + RBV 2 months | NR/ side effects |
| 9 | 1a | PegIFN + RBV 18 months | NR |
| 10 | 4 | IFN 12 months | Relapse |
| 11 | 2 | naive | NA |
IFN=interferon alpha, PegIFN=pegylated interferon alpha, RBV=ribavirin, NR=no response, NA=not applicable.